ETS1 is found to be co-expressed with MMP-1 and MMP-9 in angiosarcoma of the skin, ovarial carcinoma cells and stromal fibroblasts in breast and ovarian cancer [55–57]. Here, MMP9 is linked to ovarian cancer.